NCT06034444 (BABEL) is a clinical trial of interRAI LTCF in Residents in Longterm Care Facilities, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT06034444?

NCT06034444 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT06034444?

Interventions in NCT06034444: interRAI LTCF.

What condition does NCT06034444 study?

NCT06034444 studies Residents in Longterm Care Facilities.

Is NCT06034444 still recruiting?

NCT06034444 is currently completed. Last updated 13 September 2023.

Last reviewed 2023-09-13 · How we verify

NCT06034444: BABEL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Better tArgetting, Better Outcomes for Frail ELderly Patients

Completed Last updated 13 September 2023

What this trial tests

trial testing interRAI LTCF in Residents in Longterm Care Facilities in 5,692 participants. Completed in 31 March 2020.

Timeline

16 August 2018

Primary endpoint
31 March 2020

31 March 2020

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5,692
Start date	16 August 2018
Primary completion	31 March 2020
Estimated completion	31 March 2020
Sites	1 location across Canada

Drugs / interventions tested

interRAI LTCF

Conditions studied

Residents in Longterm Care Facilities — all drugs for Residents in Longterm Care Facilities →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

Eligibility, any sex, with Residents in Longterm Care Facilities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The acronym for this proposal, BABEL, refers to the fact that a common "language" - the interRAI risk-stratification and decision-making tool - will be used in this project, allowing several measures of care quality in long-term care facilities to be compared with those in other provinces for the first time. The impact of the use of this assessment system and associated care planning protocols will also be investigated using usual practice as the point of reference.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06034444 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 13 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06034444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing